Plague as HIV vaccine adjuvant

Area of Science:

• Immunology
• Evolutionary Biology
• Infectious Diseases

Background:

• A 32-basepair deletion mutation in the CCR5 chemokine receptor confers near-immunity to HIV infection.
• The plague bacterium, Yersinia pestis, is hypothesized as the selective pressure for this CCR5 mutation.
• Robust chemokine responses are linked to effective HIV vaccines.

Purpose of the Study:

• To explore the potential of Yersinia pestis as an adjuvant in HIV vaccine development.
• To investigate the role of Yersinia pestis in driving the CCR5 null mutation prevalence.

Main Methods:

• Review of molecular dating evidence for Yersinia pestis selective pressure.
• Analysis of the association between chemokine response and HIV vaccine efficacy.
• Hypothetical modeling of Yersinia pestis as an adjuvant.

Main Results:

• The CCR5 null mutation provides significant protection against HIV.
• Yersinia pestis is a plausible selective agent for the CCR5 null mutation.
• Stimulating a vigorous chemokine response is key for HIV vaccine success.

Conclusions:

• Yersinia pestis may serve as a valuable adjuvant in HIV vaccine strategies.
• Harnessing Y. pestis-induced chemokine responses could improve HIV vaccine efficacy.